News | May 19, 2026
Lupin debuts in Dow Jones best-in-class indices for ESG performance
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Capital infusion to accelerate Earendil’s R&D platform
The move follows AstraZeneca’s previously announced plan to complete a direct listing of its Ordinary Shares and debt securities on the New York Stock Exchange
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Subscribe To Our Newsletter & Stay Updated
